DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang operates in Diversified Metals & Mining.
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (DPM) - Net Assets
Latest net assets as of March 2024: €156.14 Billion EUR
Based on the latest financial reports, DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (DPM) has net assets worth €156.14 Billion EUR as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€907.51 Billion) and total liabilities (€751.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €156.14 Billion |
| % of Total Assets | 17.2% |
| Annual Growth Rate | -14.32% |
| 5-Year Change | -75.3% |
| 10-Year Change | N/A |
| Growth Volatility | 28.55 |
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang - Net Assets Trend (2017–2024)
This chart illustrates how DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (2017–2024)
The table below shows the annual net assets of DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | €156.14 Billion | -61.62% |
| 2023-03-31 | €406.78 Billion | -39.61% |
| 2022-03-31 | €673.57 Billion | +3.92% |
| 2021-03-31 | €648.18 Billion | +2.54% |
| 2020-03-31 | €632.11 Billion | +26.89% |
| 2019-03-31 | €498.14 Billion | +10.03% |
| 2018-03-31 | €452.72 Billion | -1.72% |
| 2017-03-31 | €460.66 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 106.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €178.73 Billion | 114.52% |
| Total Equity | €156.06 Billion | 100.00% |
DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang Competitors by Market Cap
The table below lists competitors of DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NORSK SOLAR AS NK -01
F:62L
|
$96.88K |
|
M.P.Evans Group
LSE:MPE
|
$96.93K |
|
Axiom Intelligence Acquisition Corp 1 Units
NASDAQ:AXINU
|
$96.94K |
|
Mavshack publ AB
ST:MAV
|
$97.08K |
|
ADVANCED INF SERV(ADVANC)
STU:NVAA
|
$96.87K |
|
GAIA GROW CORP.
F:GG00
|
$96.82K |
|
NAMPAK LTD RC-05
F:NNZA
|
$96.80K |
|
Galata Acquisition Corp. II Class A Ordinary Shares
NASDAQ:LATA
|
$96.79K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 406,749,000,000 to 156,063,000,000, a change of -250,686,000,000 (-61.6%).
- Net loss of 314,969,000,000 reduced equity.
- Dividend payments of 2,792,000,000 reduced retained earnings.
- Other factors increased equity by 67,075,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-314.97 Billion | -201.82% |
| Dividends Paid | €2.79 Billion | -1.79% |
| Other Changes | €67.08 Billion | +42.98% |
| Total Change | €- | -61.63% |
Book Value vs Market Value Analysis
This analysis compares DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €1159.47 | €9.70 | x |
| 2018-03-31 | €1139.50 | €9.70 | x |
| 2019-03-31 | €1253.82 | €9.70 | x |
| 2020-03-31 | €1332.72 | €9.70 | x |
| 2021-03-31 | €1461.31 | €9.70 | x |
| 2022-03-31 | €1530.07 | €9.70 | x |
| 2023-03-31 | €1023.80 | €9.70 | x |
| 2024-03-31 | €392.82 | €9.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -201.82%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -100.13%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 5.81x
- Recent ROE (-201.82%) is below the historical average (-20.70%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 6.29% | 7.04% | 0.52x | 1.72x | €-17.07 Billion |
| 2018 | 11.81% | 11.45% | 0.58x | 1.79x | €8.18 Billion |
| 2019 | 9.76% | 10.59% | 0.55x | 1.68x | €-1.19 Billion |
| 2020 | 7.70% | 8.44% | 0.39x | 2.37x | €-12.20 Billion |
| 2021 | 9.68% | 10.90% | 0.39x | 2.25x | €-1.84 Billion |
| 2022 | 9.28% | 10.07% | 0.43x | 2.15x | €-4.38 Billion |
| 2023 | -18.32% | -13.41% | 0.49x | 2.79x | €-115.19 Billion |
| 2024 | -201.82% | -100.13% | 0.35x | 5.81x | €-330.58 Billion |
Industry Comparison
This section compares DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DAINIP S'TOMO PHARM - Dusseldorf Stock Exchang (DPM) | €156.14 Billion | 6.29% | 4.81x | $96.87K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |